The entity has a beta of 0.0047, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Stratec SE's returns are expected to increase less than the market. However, during the bear market, the loss of holding Stratec SE is expected to be smaller as well. At this point, Stratec SE has a negative expected return of -0.39%. Please make sure to validate Stratec SE's risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and day median price , to decide if Stratec SE performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak
Strong
Over the last 90 days Stratec SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in January 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Begin Period Cash Flow
37.6 M
Total Cashflows From Investing Activities
-20.1 M
Stratec
Stratec SE Relative Risk vs. Return Landscape
If you would invest 670.00 in Stratec SE on September 28, 2025 and sell it today you would lose (160.00) from holding Stratec SE or give up 23.88% of portfolio value over 90 days. Stratec SE is currently producing negative expected returns and takes up 2.4064% volatility of returns over 90 trading days. Put another way, 21% of traded pink sheets are less volatile than Stratec, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
Expected Return
Risk
Assuming the 90 days horizon Stratec SE is expected to under-perform the market. In addition to that, the company is 3.38 times more volatile than its market benchmark. It trades about -0.16 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of volatility.
Stratec SE Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Stratec SE's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Stratec SE, and traders can use it to determine the average amount a Stratec SE's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1638
Best Portfolio
Best Equity
Good Returns
Average Returns
Small Returns
Cash
Small Risk
Average Risk
High Risk
Huge Risk
Negative Returns
STSEY
Based on monthly moving average Stratec SE is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Stratec SE by adding Stratec SE to a well-diversified portfolio.
Stratec SE Fundamentals Growth
Stratec Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Stratec SE, and Stratec SE fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Stratec Pink Sheet performance.
Evaluating Stratec SE's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Stratec SE has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Stratec SE has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Stratec SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany. Stratec Se operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 1372 people.
Things to note about Stratec SE performance evaluation
Checking the ongoing alerts about Stratec SE for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Stratec SE help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Stratec SE generated a negative expected return over the last 90 days
Evaluating Stratec SE's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Stratec SE's pink sheet performance include:
Analyzing Stratec SE's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Stratec SE's stock is overvalued or undervalued compared to its peers.
Examining Stratec SE's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating Stratec SE's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Stratec SE's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of Stratec SE's pink sheet. These opinions can provide insight into Stratec SE's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Stratec SE's pink sheet performance is not an exact science, and many factors can impact Stratec SE's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Additional Tools for Stratec Pink Sheet Analysis
When running Stratec SE's price analysis, check to measure Stratec SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stratec SE is operating at the current time. Most of Stratec SE's value examination focuses on studying past and present price action to predict the probability of Stratec SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stratec SE's price. Additionally, you may evaluate how the addition of Stratec SE to your portfolios can decrease your overall portfolio volatility.